Supernus Pharmaceuticals (SUPN) Payables (2011 - 2026)
Supernus Pharmaceuticals (SUPN) recorded Payables of $108.46 million in Q2 2026, up 39.5% from $77.74 million a year earlier and up 7.1% from the prior quarter.
Supernus Pharmaceuticals (SUPN) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025, Supernus Pharmaceuticals reported Payables of $107.8 million, up 41.2% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- Across earlier years, Payables came in at $76.35 million in FY2024 (-4.0%), $79.57 million in FY2023 (-84.0%), $498.31 million in FY2022 (+323.4%) and $117.68 million in FY2021 (+49.1%).
- Quarterly Payables has ranged from $72.29 million in Q3 2021 to $498.31 million in Q4 2022 over the past five years.
- On a year-over-year basis, Payables has increased for four consecutive quarters, with growth averaging 16.4% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 545.8% in Q3 2021, against a decline of 84.0% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $101.24 million (Q1 2026), $107.8 million (Q4 2025) and $108.61 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn | 108.46 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.46 Mn |
| Mar 31, 2026 | 101.24 Mn |
| Dec 31, 2025 | 107.80 Mn |
| Sep 30, 2025 | 108.61 Mn |
| Jun 30, 2025 | 77.74 Mn |
| Mar 31, 2025 | 76.89 Mn |
| Dec 31, 2024 | 76.35 Mn |
| Sep 30, 2024 | 75.80 Mn |
| Jun 30, 2024 | 82.61 Mn |
| Mar 31, 2024 | 86.40 Mn |
| Dec 31, 2023 | 79.57 Mn |
| Sep 30, 2023 | 78.47 Mn |
| Jun 30, 2023 | 83.04 Mn |
| Mar 31, 2023 | 497.85 Mn |
| Dec 31, 2022 | 498.31 Mn |
| Sep 30, 2022 | 110.30 Mn |
| Jun 30, 2022 | 133.00 Mn |
| Mar 31, 2022 | 89.43 Mn |
| Dec 31, 2021 | 117.68 Mn |
| Sep 30, 2021 | 72.29 Mn |
Supernus Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=SUPN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();